EIF2A and cancer: Regarding the relationship between PERK pathway and cancer, it has been pointed out that sustained PERK-EIF2A-ATF4 activation contributes to tumor progression and metastasis, and is ultimately associated with drug resistance [11], whereas under prolonged stress conditions of the ER, it leads to CHOP-induced apoptotic cell death [12].